Mahmoud Al Rifai
Overview
Explore the profile of Mahmoud Al Rifai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
1660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sayed A, Al Rifai M, Alwan M, El Yaman A, Shaikh A, Zoghbi W, et al.
JACC Cardiovasc Imaging
. 2025 Mar;
PMID: 40088223
No abstract available.
2.
Mansoor T, Rao B, Gupta K, Parikh S, Abramov D, Mehta A, et al.
Am J Cardiovasc Drugs
. 2024 Dec;
PMID: 39707142
Reducing low-density lipoprotein cholesterol (LDL-C) levels has been shown to reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Statins are the foundation of LDL-C lowering therapy with other non-statin...
3.
Deshotels M, Al Rifai M, Sun C, Agha A, Selvin E, Windham B, et al.
JACC Adv
. 2024 Nov;
3(11):101355.
PMID: 39539949
Background: Vital exhaustion, defined as excessive fatigue, demoralization, and irritability due to chronic stress, is independently associated with cardiovascular disease (CVD). Objectives: The purpose of this study was to examine...
4.
Mansoor T, Farrukh F, Khalid S, Abramov D, Michos E, Mehta A, et al.
Curr Probl Cardiol
. 2024 Nov;
50(1):102922.
PMID: 39522662
Hypertension is among the most prevalent diagnoses across the world and increases the risk of many serious health problems, such as stroke, heart disease, and kidney disease. Pharmacological approaches to...
5.
Razavi A, Blumenthal R, Al-Mallah M, Al Rifai M
Atherosclerosis
. 2024 Oct;
398:118618.
PMID: 39379273
No abstract available.
6.
Hay E, Zhu J, Thoma F, Marroquin O, Muluk P, Countouris M, et al.
JACC Adv
. 2024 Sep;
3(10):101231.
PMID: 39309662
Background: Data on real-world statin prescription in large, private health care networks and impacts on primary prevention of atherosclerotic cardiovascular disease (ASCVD) outcomes across race are scarce. Objectives: The purpose...
7.
Hussain A, Johansen M, Blaha M, Al-Mallah M, Cainzos-Achirica M, Nambi V, et al.
Vasc Med
. 2024 Sep;
29(6):632-639.
PMID: 39239865
Introduction: The absence of coronary artery calcium (CAC = 0) is associated with low risk of stroke events; however, predictors of incident stroke among those with CAC = 0 are...
8.
Al-Mallah M, Alwan M, Al Rifai M, Sayed A
J Nucl Cardiol
. 2024 Sep;
41:102030.
PMID: 39233112
Background: Positron emission tomography (PET) is an important tool for assessing coronary artery disease (CAD), but its widespread utilization is limited due to various factors, including limited local champion availability....
9.
Winchester D, Al Rifai M
JACC Cardiovasc Imaging
. 2024 Aug;
17(10):1211-1213.
PMID: 39115500
No abstract available.
10.
Nayfeh M, Sayed A, Alwan M, Alfawara M, Al Rifai M, Al-Mallah M
Semin Nucl Med
. 2024 Jul;
54(5):638-647.
PMID: 39034159
Coronary heart disease (CHD) remains the top cause of death due to cardiovascular conditions worldwide, with someone suffering a myocardial infarction every 40 seconds. This highlights the importance of non-invasive...